Premium
Consider drugs as a cause or an exacerbating factor in patients diagnosed with subacute cutaneous lupus erythematosus!
Author(s) -
Callen Jeffrey P.
Publication year - 2012
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.2012.11119.x
Subject(s) - medicine , hydrochlorothiazide , dermatology , hydroxychloroquine , prednisone , amlodipine , subacute cutaneous lupus erythematosus , disease , thiazide , systemic lupus erythematosus , methotrexate , lisinopril , connective tissue disease , autoimmune disease , diuretic , covid-19 , blood pressure , infectious disease (medical specialty) , angiotensin converting enzyme